Table 1 Baseline and procedural characteristics of study participants by repair and replace
MVr (n = 85) | MVR (n = 98) | *P value | |
|---|---|---|---|
Age (years) | 56 (42–70) | 60 (46–69) | 0.5756 |
Gender, females | 28 (32.9) | 34 (34.7) | 0.803 |
BMI | 24 (21–27) | 23 (21–27) | 0.7034 |
CCS class 3–4 angina | 5 (5.9) | 3 (3.1) | 0.475 |
NYHA ≥ 3 | 30 (35.3) | 42 (42.9) | 0.296 |
MI within 90 days of surgery | 2 (2.4) | 0 (0.0) | 0.214 |
Previous cardiac surgery | 7 (8.2) | 9 (9.2) | 0.821 |
Diabetes | 7 (8.2) | 13 (13.3) | 0.277 |
Hypertension | 35 (41.2) | 41 (42.3) | 0.935 |
Current smoker | 17 (20.0) | 24 (24.5) | 0.468 |
History of dialysis | 7 (8.6) | 9 (9.8) | 0.796 |
History of respiratory disease | 6 (7.1) | 16 (16.3) | 0.055 |
History of stroke/TIA | 14 (16.5) | 25 (25.5) | 0.136 |
Extracardiac arteriopathy | 2 (2.4) | 6 (6.2) | 0.287 |
Non-SR on admission | 9 (10.6) | 11 (11.2) | 0.891 |
LVEF | |||
> 50% | 64 (75.3) | 66 (67.4) | 0.388 |
31–50% | 20 (23.5) | 28 (28.6) | |
≤ 30% | 1 (1.2) | 4 (4.1) | |
Logistic EuroSCORE | 8 (4–18) | 15 (6–29) | 0.0007 |
Urgency | |||
Elective | 23 (27.1) | 8 (8.2) | 0.002 |
Urgent | 45 (52.9) | 62 (63.3) | |
Emergency | 16 (18.8) | 28 (28.6) | |
Salvage | 1 (1.2) | 0 (0) | |
Concomitant cardiac surgery | |||
Valve alone | 63 (74.1) | 80 (81.6) | 0.329 |
Valve + CABG | 8 (9.4) | 4 (4.1) | |
Valve + other^ | 13 (15.3) | 11 (11.2) | |
Valve + CABG + other^ | 1 (1.2) | 3 (3.1) | |
Active IE | 51 (60.0) | 84 (85.7) | < 0.0001 |
MV Regurgitation | 84 (98.8) | 92 (94.9) | 0.374 |
Concomitant valve surgery | |||
Mitral only | 71 (83.5) | 72 (73.5) | 0.205 |
Mitral + Aortic | 12 (14.1) | 19 (19.4) | |
Mitral + Tricuspid | 2 (2.4) | 3 (3.1) | |
Mitral + Aortic + Tricuspid | 0 (0) | 4 (4.1) | |
Cumulative cross clamp time | 76 (55–98) | 82 (64–106) | 0.1476 |
Cumulative bypass time | 103 (75–123) | 111 (85–145) | 0.0561 |
Later year of surgery (early 2005–2012 vs late 2013–2021) | 53 (62.4) | 62 (63.3) | 0.899 |